These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 8768838

  • 1. Power spectral analysis of heart rate in hyperthyroidism.
    Cacciatori V, Bellavere F, Pezzarossa A, Dellera A, Gemma ML, Thomaseth K, Castello R, Moghetti P, Muggeo M.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2828-35. PubMed ID: 8768838
    [Abstract] [Full Text] [Related]

  • 2. Power spectral analysis of heart rate in hypothyroidism.
    Cacciatori V, Gemma ML, Bellavere F, Castello R, De Gregori ME, Zoppini G, Thomaseth K, Moghetti P, Muggeo M.
    Eur J Endocrinol; 2000 Sep; 143(3):327-33. PubMed ID: 11022173
    [Abstract] [Full Text] [Related]

  • 3. Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability.
    Chen JL, Chiu HW, Tseng YJ, Chu WC.
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):611-6. PubMed ID: 16712661
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of autonomic nervous system function with heart rate variability analysis in patients with hyperthyroidism and during euthyroidism after pharmacologic and surgical treatment].
    Barczyński M, Tabor S, Thor P.
    Folia Med Cracov; 1997 Jun; 38(3-4):27-35. PubMed ID: 10481379
    [Abstract] [Full Text] [Related]

  • 5. Power spectral analysis of variations in heart rate in patients with hyperthyroidism or hypothyroidism.
    Inukai T, Takanashi K, Kobayashi H, Fujiwara Y, Tayama K, Aso Y, Takemura Y.
    Horm Metab Res; 1998 Aug; 30(8):531-5. PubMed ID: 9761386
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities.
    Sgarbi JA, Villaça FG, Garbeline B, Villar HE, Romaldini JH.
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1672-7. PubMed ID: 12679455
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sympathovagal imbalance in thyroid dysfunctions in females: correlation with thyroid profile, heart rate and blood pressure.
    Karthik S, Pal GK, Nanda N, Hamide A, Bobby Z, Amudharaj D, Pal P.
    Indian J Physiol Pharmacol; 2009 Apr; 53(3):243-52. PubMed ID: 20329371
    [Abstract] [Full Text] [Related]

  • 11. [The effect of orthostatic provocation on the spectral pattern of heart rate variability in healthy subjects].
    Rozentryt P, Trzos G, Strłojewski D, Kozlowski JW, Maciejewski M.
    Przegl Lek; 1996 Apr; 53(7):534-9. PubMed ID: 8975288
    [Abstract] [Full Text] [Related]

  • 12. Altered cardiovascular vagal responses in nonelderly female patients with subclinical hyperthyroidism and no apparent cardiovascular disease.
    Portella RB, Pedrosa RC, Coeli CM, Buescu A, Vaisman M.
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):290-4. PubMed ID: 17524031
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Heart rate variability and turbulence in hyperthyroidism before, during, and after treatment.
    Osman F, Franklyn JA, Daykin J, Chowdhary S, Holder RL, Sheppard MC, Gammage MD.
    Am J Cardiol; 2004 Aug 15; 94(4):465-9. PubMed ID: 15325930
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Autonomic control of heart period in duodenal ulcer patients insights from spectral analysis of heart rate variability.
    Lucini D, Cerchiello M, Basilisco G, Cainelli M, Bianchi PA, Fiorelli G, Malliani A, Pagani M.
    Auton Neurosci; 2000 Nov 01; 84(3):122-9. PubMed ID: 11111844
    [Abstract] [Full Text] [Related]

  • 18. Sympatho-vagal control of heart rate variability in patients treated with suppressive doses of L-thyroxine for thyroid cancer.
    Casu M, Cappi C, Patrone V, Repetto E, Giusti M, Minuto F, Murialdo G.
    Eur J Endocrinol; 2005 Jun 01; 152(6):819-24. PubMed ID: 15941920
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.